Act vs IOTOX Algorithm
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Act
Read full descriptionHide full description
A genetic result can answer one question—and immediately create ten more. What does this mean for me? What screenings do I need? When should I start? How often do I need them? What should I ask my doctor? ACT-GEN helps turn those questions into a plan you can understand and act on. Built for people with Lynch syndrome or BRCA-related hereditary cancer risk, ACT-GEN brings education, prevention strategies, appointments, and trusted resources together in one place—so your care feels less scattered and easier to navigate. With ACT-GEN, you can: - Understand your condition with clear, visual education about Lynch syndrome, BRCA-related risk, and why preventive care matters. - Build your prevention plan with screening and prevention strategies based on your age and genetic variant. - Know why each strategy matters and when it may be recommended. - Stay on top of your care by tracking upcoming, to-schedule, and overdue appointments. - Prepare for appointments with saved preparation notes and questions for your provider. - Capture key visit details including notes, results, voice recordings, and changes to your prevention plan. - Learn from doctor-vetted resources about screening, prevention, cascade testing, risk-reducing surgery, and more. Your genetic risk is part of your story. ACT-GEN helps you understand what comes next and keep moving forward, one step at a time. ACT-GEN is designed to support—not replace—the relationship between you and your healthcare team. Disclaimer: The information and guidance provided by ACT-GEN are intended for educational and care-tracking purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding your screening, prevention, and treatment decisions. Privacy Policy: https://georgiactsa.org/research/commercialization/privacy/hometown-privacy-policy.html
IOTOX Algorithm
This app provides clinical management algorithms for evaluating, diagnosing, and treating toxicities associated with cancer immunotherapies. It guides physicians on best practices for managing side effects that can arise during cancer treatment.
- Clinical management algorithms
- Evaluation of toxicities
- Diagnosis of side effects
- Treatment of immunotherapy toxicities
- Best practices for patient care
Read full descriptionHide full description
Immunotherapies have become essential in treating advanced malignancies. However, immunotherapies can attack healthy cells, leading to toxicities or side effects. To address how to best treat patients with these toxicities, the Internal Medicine division has collaborated with the Cancer Medicine division, as well as other divisions at MD Anderson, to create the Immuno-Oncology Toxicity (IOTOX) Leaders Group. Clinical management algorithms depict best practices for evaluating, diagnosing, and treating specific conditions that arise during the course of cancer treatment. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.
Screenshots
Verdict
Act and IOTOX Algorithm are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Act ships an update every 3 weeks, IOTOX Algorithm every 6 weeks. The most recent releases landed on November 7, 2026 and November 18, 2026 respectively.
| Parameter | Act | IOTOX Algorithm |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (1 ratings) — better |
| Number of ratings | — | 1 — better |
| Update frequency | Every 3 weeks — better | Every 6 weeks |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | — | Free |
| Devices | iPhone | iPhone |
| Requires iOS | 17.0 — better | 18.0 |
| Further details — not scored | ||
| Size | 63 MB | 7 MB |
| Age rating | 17+ | 17+ |
| Developer | Emory University | MD Anderson Cancer Center |
In-app purchases
Act
No in-app purchases
IOTOX Algorithm
No in-app purchases









